miR-7 Reduces High Glucose Induced-damage Via HoxB3 and PI3K/AKT/mTOR Signaling Pathways in Retinal Pigment

Zhongyi Yang1, Hanying Hu1, Yuling Zou1

  • 1Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Abstract

Insights

MicroRNA-7 (miR-7) was found to reduce apoptosis and regulate cell proliferation in diabetic retinopathy (DR) by influencing the HoxB3 gene and PI3K/AKT/mTOR pathway. This suggests miR-7 is a potential therapeutic target for DR.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Endocrinology

Background:

  • Diabetic retinopathy (DR) is a significant complication of diabetes mellitus.
  • Understanding the molecular mechanisms underlying DR pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of microRNA-7 (miR-7) in regulating cell proliferation in diabetic retinopathy.
  • To explore the involvement of the HoxB3 gene and the PI3K/AKT/mTOR signaling pathway in miR-7-mediated effects on retinal cells.

Main Methods:

  • Human retinal pigment epithelial cells (ARPE-19) were cultured under high glucose conditions to mimic diabetic environments.
  • Cells were transfected with miR-7 mimics or inhibitors to modulate miR-7 expression.
  • Cell viability, apoptosis, and gene expression (Hoxb3, PI3K, AKT, mTOR) were assessed using PCR and protein analysis.

Main Results:

  • High glucose conditions reduced cell viability and increased apoptosis.
  • Transfection with miR-7 mimics counteracted the effects of high glucose by reducing apoptosis and upregulating miR-7 expression.
  • miR-7 mimics significantly downregulated the expression of HoxB3, mTOR, p-PI3K, and p-AKT at both mRNA and protein levels.

Conclusions:

  • MiR-7 plays a critical role in regulating retinal epithelial cell growth and apoptosis in the context of diabetic retinopathy.
  • The findings highlight the involvement of the HoxB3 gene and the PI3K/AKT/mTOR pathway in miR-7's function.
  • MiR-7 represents a promising therapeutic target for the prevention and treatment of diabetic retinopathy.